In the context of gliomas, levels of DNA methylation are associated with the IDH-mutation status of the tumor with IDH-mutant gliomas tending to acquire a hypermethylated phenotype, commonly referred to as the glioma CpG island methylator phenotype or G-CIMP (107). The gene discussed is IDH1; the disease is central nervous system cancer.